Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is FGFR3, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for intrahepatic cholangiocarcinoma; and TYRA-430 for the treatment of hepatocellular carcinoma. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.
| Business Activity | PASS |
| Debt Ratio | N/A |
| Cash Ratio | N/A |
| Receivables Ratio | N/A |
| Revenue Ratio | N/A |
| Overall | INSUFFICIENT DATA |
$1.6B
6.77
0.789
11
$5.7M
1.29
8.82
0.3%
87
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($51.15, 11 analysts) | |||
| 10 | $331.70 | +$179.80 (54%) | 3.6R |
| 50 | $1,658.50 | +$899.00 (54%) | 3.6R |
| 100 | $3,317.00 | +$1,798.00 (54%) | 3.6R |
- Elevated short interest (8.82 days to cover)
A single score combining all analytical layers below. A is strongest, D is weakest.
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
| Ticker | Correlation |
|---|---|
| NRIX | 0.412 |
| KYMR | 0.402 |
| RCUS | 0.390 |
| ARKG | 0.389 |
| AURA | 0.376 |
| Ticker | Correlation |
|---|---|
| PSO.KA | -0.137 |
| SMWH.L | -0.135 |
| ULVR.L | -0.135 |
| ZAIN.KW | -0.134 |
| SENERGY.KW | -0.127 |
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.